Versant Capital Management, Inc

Position in FLGT — Fulgent Genetics, Inc.

CIK 1735057 PHOENIX, AZ

Position in FLGT

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$20,458

-$22,328 QoQ

Shares Held

997

-63.0% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 142 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Versant Capital Management, Inc holds $4,848,853 across 25 Diagnostics & Research names. FLGT ranks #20 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	A	Agilent Technologies, Inc.	4,957	$658,438
2	ILMN	Illumina, Inc.	3,622	$636,856
3	IDXX	Idexx Laboratories Inc /De	1,014	$533,810
4	CRL	Charles River Laboratories International, Inc.	1,963	$445,188
5	IQV	Iqvia Holdings Inc.	2,291	$442,667
6	TMO	Thermo Fisher Scientific Inc.	858	$430,166
7	RVTY	Revvity, Inc.	2,280	$253,672
8	NTRA	Natera, Inc.	779	$211,459

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,458	997	-63.0%	Shares	Sole	2026-07-02
2026-03-31	$42,786	2,691	+84.7%	Shares	Sole	2026-04-07
2025-12-31	$38,275	1,457	0.0%	Shares	Sole	2026-01-08
2025-09-30	$32,928	1,457	-31.3%	Shares	Sole	2025-10-27
2025-06-30	$42,145	2,120	+48.7%	Shares	Sole	2025-07-07
2025-03-31	$24,099	1,426	+43.8%	Shares	Sole	2025-04-03
2024-12-31	$18,322	992	+104.1%	Shares	Sole	2025-01-03
2024-09-30	$10,560	486	+43.8%	Shares	Sole	2024-10-07
2024-06-30	$6,631	338	+164.1%	Shares	Sole	2024-07-08
2024-03-31	$2,777	128	0.0%	Shares	Sole	2024-04-03
2023-12-31	$3,700	128	+172.3%	Shares	Sole	2024-01-08
2023-09-30	$1,256	47	-87.1%	Shares	Sole	2023-10-12
2023-06-30	$13,478	364	-18.9%	Shares	Sole	2023-07-10
2023-03-31	$14,017	449	—	Shares	Sole	2023-04-10
No filing history on record for this holder in this stock.